Recent research indicates that GLP-1 agonists, such as Ozempic, may not only aid in weight loss but also reduce cravings for addictive substances like alcohol. This effect is linked to the lateral septum, a brain region that plays a crucial role in processing rewards and craving…
A recent study indicates that long COVID may lead to significant damage in the brain's dopamine system, affecting motivation and cognitive function. Researchers found that individ…
A recent study from the University of Southern California highlights the role of gut-brain signals in forming food-related memories. Researchers found that nutrient-rich foods enh…
Recent research has uncovered that metformin, a widely used medication for type 2 diabetes, not only lowers blood glucose levels but also affects brain function. This study highli…
Recent research indicates that signals from the gut may influence how food-related experiences are remembered. Conducted by USC researchers, the study found that consuming nutrien…
A recent study funded by the NIH has uncovered how newer oral GLP-1 drugs, including orforglipron and danuglipron, affect the brain's reward circuits in mice, potentially reducing…
The FDA has approved setmelanotide, a new treatment for acquired hypothalamic obesity, following the results of the Phase 3 TRANSCEND clinical trial. This condition, often affecti…